Status:
COMPLETED
The Evolution and Management of Migraine Recurrence Beyond 24 Hours
Lead Sponsor:
Rowan University
Collaborating Sponsors:
Endo Pharmaceuticals
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Brief Summary
What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?
Eligibility Criteria
Inclusion
- Female and male patients at University Headache Center with \> 6 month diagnosis of migraine with and/or without aura (ICHD-II)
- Greater than or equal to 18 years old
Exclusion
- Greater than 15 days/month total headache days
- Analgesic use greater than 15 days/month (other than aspirin less than or equal to 325mg/d)
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00754611
Start Date
December 1 2008
End Date
December 1 2010
Last Update
October 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Medicine and Dentistry of New Jersey
Stratford, New Jersey, United States, 08084